Conformation of the transmembrane domain of the c-erbB-2 oncogene-encoded protein in its monomeric and dimeric states
- 1 January 1995
- journal article
- Published by Springer Nature in Protein Journal
- Vol. 14 (1) , 33-40
- https://doi.org/10.1007/bf01902842
Abstract
The human c-erbB-2 oncogene is homologous to the ratneu oncogene, both encoding transmembrane growth factor receptors. Overexpression and point mutations in the transmembrane domain of the encoded proteins in both cases have been implicated in cell transformation and carcinogenesis. In the case of theneu protein, it has been proposed that these effects are mediated by conformational preferences for anα-helix in the transmembrane domain, which facilitates receptor dimerization, an important step in the signal transduction process. To examine whether this is the case for c-erbB-2 as well, we have used conformational energy analysis to determine the preferred three-dimensional structures for the transmembrane domain of the c-erbB-2 protein from residues 650 to 668 with Val (nontransforming) and Glu (transforming) at position 659. The global minimum energy conformation for the Val-659 peptide from the normal, nontransforming protein was found to contain several bends, whereas the global minimum energy conformation for Glu-659 peptide from the mutant, transforming protein was found to beα-helical. Thus, the difference in conformational preferences for these transmembrane domains may explain the difference in transforming ability of these proteins. The presence of higher-energyα-helical conformations for the transmembrane domain from the normal Val-659 protein may provide an explanation for the presence of a transforming effect from overexpression of c-erbB-2. In addition, docking of the oncogenic sequences in theirα-helical and bend conformations shows that the all-α-helical dimer is clearly favored energetically over the bend dimer.Keywords
This publication has 25 references indexed in Scilit:
- Conformation of the transmembrane domain of the epidermal growth factor receptorProtein Journal, 1994
- The c-erbB-2 Protein in Oncogenesis: Molecular Structure to Molecular EpidemiologyCritical Reviews™ in Oncogenesis, 1994
- Determination of a fragment of the c-erbB-2 translational product p185 in serum of breast cancer patientsZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Energy parameters in polypeptides. 10. Improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm, with application to proline-containing peptidesThe Journal of Physical Chemistry, 1992
- Conformational changes induced by the transforming amino acid substitution in the transmembrane domain of theneu oncogene-encoded p185 proteinProtein Journal, 1989
- Correlation of β‐bend conformations of tetrapeptides with their activities in CD4‐receptor binding assaysInternational Journal of Peptide and Protein Research, 1989
- GROWTH FACTOR RECEPTOR TYROSINE KINASESAnnual Review of Biochemistry, 1988
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984
- Computed conformational states of the 20 naturally occurring amino acid residues and of the prototype residue α-aminobutyric acidMacromolecules, 1983
- Energy parameters in polypeptides. 9. Updating of geometrical parameters, nonbonded interactions, and hydrogen bond interactions for the naturally occurring amino acidsThe Journal of Physical Chemistry, 1983